This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Matthias Arlt: Patent Activity in Pharmaceutical Innovation.
Introduction
Matthias Arlt is an inventor associated with Berlin, Germany, and Bayer Aktiengesellschaft. His patent work concerns pharmaceutical compounds and their potential use in treating disease.
Latest Patents
The provided information lists one patent for Matthias Arlt: “Phosphorus Derivatives as SOS1 Inhibitors.” The invention covers phosphorus derivatives, methods for preparing them, useful intermediate compounds, pharmaceutical compositions, and combinations with other active ingredients. It also describes using these compounds to manufacture treatments or preventive medicines for diseases, particularly hyperproliferative disorders associated with SOS1. The compounds may be used alone or in combination with other active ingredients. The listed patent count is 1 patent.
Career Highlights
Arlt’s listed patent connects his inventive work with pharmaceutical research at Bayer Aktiengesellschaft. The invention focuses on SOS1 inhibitors and their potential therapeutic applications.
Collaborations
The provided information names Felix Pape and Steffen Gressies as Arlt’s coworkers. Their specific roles in the patent or related research are not stated.
Conclusion
Matthias Arlt’s listed patent reflects work on phosphorus-based SOS1 inhibitors and their potential use in pharmaceutical compositions for treating or preventing disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile